Symphony Financial’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
16,641
+13,427
| +418% | +$2.26M | 0.37% | 62 |
|
|
2025
Q1 | $558K | Sell |
3,214
-10,368
| -76% | -$1.8M | 0.33% | 54 |
|
|
2024
Q4 | $2.34M | Buy |
13,582
+102
| +0.8% | +$17.5K | 0.37% | 60 |
|
|
2024
Q3 | $2.63M | Buy |
13,480
+493
| +4% | +$96K | 0.43% | 57 |
|
|
2024
Q2 | $2.19M | Buy |
12,987
+949
| +8% | +$160K | 0.4% | 59 |
|
|
2024
Q1 | $2.19M | Sell |
12,038
-1,095
| -8% | -$199K | 0.51% | 51 |
|
|
2023
Q4 | $2.12M | Buy |
13,133
+7,311
| +126% | +$1.18M | 0.46% | 56 |
|
|
2023
Q3 | $823K | Sell |
5,822
-1,439
| -20% | -$204K | 0.2% | 84 |
|
|
2023
Q2 | $967K | Sell |
7,261
-806
| -10% | -$107K | 0.24% | 81 |
|
|
2023
Q1 | $1.27M | Sell |
8,067
-349
| -4% | -$55.1K | 0.33% | 62 |
|
|
2022
Q4 | $1.38M | Sell |
8,416
-963
| -10% | -$158K | 0.36% | 58 |
|
|
2022
Q3 | $1.34M | Sell |
9,379
-55
| -0.6% | -$7.85K | 0.44% | 55 |
|
|
2022
Q2 | $1.45M | Sell |
9,434
-2,998
| -24% | -$462K | 0.43% | 49 |
|
|
2022
Q1 | $2.15M | Buy |
12,432
+3,873
| +45% | +$671K | 0.51% | 42 |
|
|
2021
Q4 | $1.16M | Buy |
8,559
+1,791
| +26% | +$243K | 0.32% | 66 |
|
|
2021
Q3 | $737K | Sell |
6,768
-2,445
| -27% | -$266K | 0.26% | 66 |
|
|
2021
Q2 | $1.04M | Buy |
9,213
+658
| +8% | +$74.2K | 0.35% | 56 |
|
|
2021
Q1 | $902K | Buy |
8,555
+2,205
| +35% | +$232K | 0.24% | 68 |
|
|
2020
Q4 | $669K | Sell |
6,350
-1,259
| -17% | -$133K | 0.24% | 73 |
|
|
2020
Q3 | $666K | Buy |
7,609
+73
| +1% | +$6.39K | 0.27% | 60 |
|
|
2020
Q2 | $740K | Buy |
7,536
+2,230
| +42% | +$219K | 0.36% | 47 |
|
|
2020
Q1 | $399K | Buy |
+5,306
| New | +$399K | 0.28% | 59 |
|